125 related articles for article (PubMed ID: 26744433)
1. Serendipity in splendid isolation: rapamycin.
Rao VK
Blood; 2016 Jan; 127(1):5-6. PubMed ID: 26744433
[TBL] [Abstract][Full Text] [Related]
2. Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial.
Bride KL; Vincent T; Smith-Whitley K; Lambert MP; Bleesing JJ; Seif AE; Manno CS; Casper J; Grupp SA; Teachey DT
Blood; 2016 Jan; 127(1):17-28. PubMed ID: 26504182
[TBL] [Abstract][Full Text] [Related]
3. Rapid regression of lymphadenopathy upon rapamycin treatment in a child with autoimmune lymphoproliferative syndrome.
Janić MD; Brasanac CD; Janković JS; Dokmanović BL; Krstovski RN; Kraguljac Kurtović JN
Pediatr Blood Cancer; 2009 Dec; 53(6):1117-9. PubMed ID: 19588524
[TBL] [Abstract][Full Text] [Related]
4. Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS).
Teachey DT; Obzut DA; Axsom K; Choi JK; Goldsmith KC; Hall J; Hulitt J; Manno CS; Maris JM; Rhodin N; Sullivan KE; Brown VI; Grupp SA
Blood; 2006 Sep; 108(6):1965-71. PubMed ID: 16757690
[TBL] [Abstract][Full Text] [Related]
5. Use of Sirolimus (Rapamycin) for Treatment of Cytopenias and Lymphoproliferation Linked to Autoimmune Lymphoproliferative Syndrome (ALPS). Two Case Reports.
Cayrol J; Garrido Colino C
J Pediatr Hematol Oncol; 2017 May; 39(4):e187-e190. PubMed ID: 28234735
[TBL] [Abstract][Full Text] [Related]
6. Successful Treatment of Recurrent Autoimmune Cytopenias in the Context of Sinus Histiocytosis With Massive Lymphadenopathy Using Sirolimus.
Cooper SL; Arceci RJ; Gamper CJ; Teachey DT; Schafer ES
Pediatr Blood Cancer; 2016 Feb; 63(2):358-60. PubMed ID: 26452062
[TBL] [Abstract][Full Text] [Related]
7. [Immunosuppressive treatment in autoimmunological blood diseases (author's transl)].
Szmigiel Z; Korzeniowska D
Przegl Lek; 1975; 32(12):896-909. PubMed ID: 1219921
[No Abstract] [Full Text] [Related]
8. Rapamycin (sirolimus) as a steroid-sparing agent in dermatomyositis.
Nadiminti U; Arbiser JL
J Am Acad Dermatol; 2005 Feb; 52(2 Suppl 1):17-9. PubMed ID: 15692505
[TBL] [Abstract][Full Text] [Related]
9. Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndrome.
Rao VK; Dugan F; Dale JK; Davis J; Tretler J; Hurley JK; Fleisher T; Puck J; Straus SE
Br J Haematol; 2005 May; 129(4):534-8. PubMed ID: 15877736
[TBL] [Abstract][Full Text] [Related]
10. Treatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndrome.
Teachey DT; Greiner R; Seif A; Attiyeh E; Bleesing J; Choi J; Manno C; Rappaport E; Schwabe D; Sheen C; Sullivan KE; Zhuang H; Wechsler DS; Grupp SA
Br J Haematol; 2009 Apr; 145(1):101-6. PubMed ID: 19208097
[TBL] [Abstract][Full Text] [Related]
11. Refractory Autoimmune Cytopenia in a Young Boy with a Novel LRBA Mutation Successfully Managed with Sirolimus.
Banday AZ; Jindal AK; Tyagi R; Singh S; Patra PK; Kumar Y; Suri D; Rawat A
J Clin Immunol; 2020 Nov; 40(8):1184-1186. PubMed ID: 32915433
[No Abstract] [Full Text] [Related]
12. Safety, efficacy, and immune reconstitution after rituximab therapy in pediatric patients with chronic or refractory hematologic autoimmune cytopenias.
Rao A; Kelly M; Musselman M; Ramadas J; Wilson D; Grossman W; Shenoy S
Pediatr Blood Cancer; 2008 Apr; 50(4):822-5. PubMed ID: 17570702
[TBL] [Abstract][Full Text] [Related]
13. Drug therapy. Immunosuppressive agents. I.
Kaplan SR; Calabresi P
N Engl J Med; 1973 Nov; 289(18):952-5. PubMed ID: 4582749
[No Abstract] [Full Text] [Related]
14. [Immunosuppressive cytostatic preparations in the therapy of certain diseases].
Petrov NS; Dygin VP; Viazitskiĭ PO; Tokarev NF
Voen Med Zh; 1975 Sep; (9):43-7. PubMed ID: 1181721
[No Abstract] [Full Text] [Related]
15. Alternatives to steroids?! Beneficial effects of immunosuppressant drugs in autoimmune pancreatitis.
Seleznik G; Graf R
Gut; 2014 Mar; 63(3):376-7. PubMed ID: 23633291
[No Abstract] [Full Text] [Related]
16. New hope for relapsed and refractory multiple myeloma.
Leleu X
Lancet Oncol; 2013 Oct; 14(11):1028-1029. PubMed ID: 24007745
[No Abstract] [Full Text] [Related]
17. [CD20 antibody for the treatment of systemic autoimmune diseases].
Tanaka Y
Nihon Rinsho; 2005 May; 63 Suppl 5():728-33. PubMed ID: 15954437
[No Abstract] [Full Text] [Related]
18. Prevention of murine lupus disease in (NZBxNZW)F1 mice by sirolimus treatment.
Ramos-Barrón A; Piñera-Haces C; Gómez-Alamillo C; Santiuste-Torcida I; Ruiz JC; Buelta-Carrillo L; Merino R; de Francisco AL; Arias M
Lupus; 2007; 16(10):775-81. PubMed ID: 17895299
[TBL] [Abstract][Full Text] [Related]
19. Sirolimus rescue therapy for refractory rejection in renal transplant recipients.
Hong JC; Kahan BD
Transplant Proc; 2001; 33(1-2):1033. PubMed ID: 11267178
[No Abstract] [Full Text] [Related]
20. Proliferation signal inhibitors for the treatment of refractory autoimmune rheumatic diseases: a new therapeutic option.
Yoon KH
Ann N Y Acad Sci; 2009 Sep; 1173():752-6. PubMed ID: 19758225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
